Table 4.
Poststroke HF | HF without history of stroke | |||
---|---|---|---|---|
r | P | r | P | |
Calcium-PTH | −0.328 | 0.047* | −0.273 | <0.001 |
Calcium-osteocalcin | 0.3226 | 0.052* | 0.139 | 0.034* |
Calcium-BAP | 0.137 | 0.434 | 0.16 | 0.015 |
Osteocalcin-eGFR | −0.525 | 0.001 | −0.346 | <0.001 |
Calcium-eGFR | −0.464 | 0.004 | −0.075 | 0.250 |
DPD/Cr-NTx/Cr | 0.779 | <0.001 | 0.380 | <0.001 |
DPD/Cr-BSI | −0.926 | <0.001 | −0.690 | <0.001 |
NTx/Cr-BSI | −0.952 | <0.001 | −0.876 | <0.001 |
Age-eGFR | −0.443 | 0.005 | −0.337 | <0.001 |
Phosphate-calcium | 0.415 | 0.011 | 0.055 | 0.399 |
Phosphate-DPD/Cr | 0.580 | 0.001 | 0.208 | 0.003 |
Phosphate-osteocalcin | 0.489 | 0.002 | 0.123 | 0.061 |
Phosphate-BAP | 0.215 | 0.216 | 0.169 | 0.01 |
Phosphate-NTx/Cr | 0.478 | 0.006 | 0.079 | 0.263 |
Phosphate-BSI | −0.531 | 0.003 | −0.109 | 0.126 |
Phosphate-eGFR | −0.32 | 0.054* | −0.173 | 0.008 |
PTH-vitamin B12 | 0.365 | 0.028* | 0.016 | 0.817 |
BAP-vitamin B12 | 0.442 | 0.009 | 0.188 | 0.006 |
Values for all variables other than age were log transformed before analysis.
PTH: parathyroid hormone; eGFR: estimated glomerular filtration rate; DPD/Cr: urinary deoxypyridinoline corrected for urinary creatinine concentration; NTx/Cr: cross-linked N-telopeptide of type 1 collagen corrected for urinary creatinine concentration; BSI: bone balance status index. *Nonsignificant (P > 0.005) correlations when Bonferroni and Sidak adjustments for multiplicity were adopted.